Navigation Links
Study of energy and health in Africa focuses spotlight on charcoal and forest management

because there is a well developed market and you don't need expensive infrastructure like refineries and processing. So, while fossil fuels are in fact better for health and better for climate, they are more expensive and a lot harder to get out."

Charcoal burns cleaner and produces less indoor pollution than wood, but the current inefficient production method in Africa is one of the most polluting for the global environment and potentially destructive to African forests. The researchers' analysis shows that charcoal can provide comparable health benefits of 1 to 2.8 million avoided deaths. However, scenarios that forecast large shifts to charcoal without improvements in harvesting and production would lead to severe increases in greenhouse gas emissions, they said, with over 15 billion tons of carbon released into the atmosphere by 2050.

"Most charcoal is produced in Africa by one or two guys going out in the woods, almost always without a permit and on somebody else's land, cutting down a tree or two, chopping it up, lighting it, covering it with dirt, and then hovering around it for two to four days while it becomes charcoal," Kammen said. "It's no surprise it's not generally a high-efficiency operation."

The authors found that by creating the technological and policy tools for transitioning to higher efficiency charcoal production technologies and sustainable harvesting, like those used today in countries such as Brazil and Thailand, greenhouse gas emissions can be reduced by 45 percent in a gradual transition scenario, and by 66 percent in a rapid transition case.

"This study shows that choosing energy technologies with an eye toward improving health and quality of life in one of the world's most impoverished areas offers us opportunity to significantly reduce premature deaths, especially among women and children," said Ezzati.


'"/>

Source:University of California - Berkeley


Page: 1 2 3

Related biology news :

1. Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down
2. Emory Study Tests Bone Marrow Stem Cells to Improve Circulation in Legs
3. UCLA Study Shows One-Third of Drug Ads in Medical Journals Do Not Contain References Supporting Medical Claims
4. Study Demonstrates Gene Expression Microarrays are Comparable and Reproducible
5. Study Links Ebola Outbreaks To Animal Carcasses
6. Breakthrough Microarray-based Technology for the Study of Cancer
7. NYU Study Reveals How Brains Immune System Fights Viral Encephalitis
8. Study finds more than one-third of human genome regulated by RNA
9. Leukemia Drug Breakthrough Study In New England Journal Of Medicine
10. Study identifies predictors of HIV drug resistance in patients beginning triple therapy
11. New Study from Affymetrix Laboratories Points to Changing View of How Genome Works

Post Your Comments:
(Date:11/25/2009)... may be used to boost resistance to, or slow, the ... Medicine researchers report in a study published .... , Parkinson,s disease is caused by a degenerat... known as the substantia nigra, which is responsib... dopamine in late-stage Parkinson,s causes symptom...
(Date:11/25/2009)... Research Laboratory in the University of Haifa,s ...gious Johnson & Johnson Focused Funding grant for ...age in Parkinson,s disease. The award, which is gr...tion and excellence in science, was announced in 2...t an event at the Hyatt Regency Hotel in New Jerse...
(Date:11/25/2009)...ors recently received funding from the National Sc...cial to understanding the environment. The three g...ssistant professor in the Department of Biological...ate research projects. , His first project, titl...unctions from the Leaf to the Landscape," will exa...
Breaking Biology News(10 mins):Hormone ghrelin can boost resistance to Parkinson's disease 2Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Kent State University professors focus research on the environment with grants totaling $890,000 2New Nominee for WHO Regional Director for Europe 57339 1New Nominee for WHO Regional Director for Europe 57339 2Video 3A NFL Season Kicks Off With Campaign to Know Your Stats About Prostate Cancer 57336 1Video 3A NFL Season Kicks Off With Campaign to Know Your Stats About Prostate Cancer 57336 2Video 3A NFL Season Kicks Off With Campaign to Know Your Stats About Prostate Cancer 57336 3Video 3A NFL Season Kicks Off With Campaign to Know Your Stats About Prostate Cancer 57336 4GenVec Receives NASDAQ Notice of Minimum Bid Price Non Compliance 57333 1GenVec Receives NASDAQ Notice of Minimum Bid Price Non Compliance 57333 2GenVec Receives NASDAQ Notice of Minimum Bid Price Non Compliance 57333 3
...sts have demonstrated a new way to assess the pote...--a technique that could also be used to monitor a...isticated, noninvasive medical imaging tools. Scie...en National Laboratory, whose findings are reporte...Medicine,s Journal of Nuclear Medicine, used posit...
...s newest polymer innovation, the first DuPont poly...ognized by the China State Intellectual Property O... Visionary Innovation" at a recent award ceremony....ive the 2005 "New Technologies in Renewable Materi...d Environmental Conference, sponsored by the Socie...
...e sclerosis (MS) can be an unpredictable disease. ...healthy nerve cells and disrupts normal nerve sign...s—including tingling, paralysis, pain, fatigue, an...in combination, sporadically or persistently. Alth...-ups are common in the majority of patients. , MS...
Other Biology News:PET/MRI scans may help unravel mechanisms of prenatal drug damage 2PET/MRI scans may help unravel mechanisms of prenatal drug damage 3PET/MRI scans may help unravel mechanisms of prenatal drug damage 4DuPont's first biologically derived polymer receives global recognition 2Gene Signatures Predict Interferon Response For Multiple Sclerosis Patients 2
(Date:11/24/2009)...lif.,Nov.24/PRNewswire-FirstCall/--NeurogesX,Inc.(...evelopingandcommercializingnovelpainmanagementther...dChiefExecutiveOfficer,isscheduledtopresentatthe21...ecember1-2,2009atTheNewYorkPalaceHotelinNewYork,Ne...nancialOfficer,willbeavailabletorespondtoquestions...
(Date:11/24/2009)...cacyendpointhasbeenmetforpatientswithadvanced-stag...Nov.24/PRNewswire-FirstCall/-AEternaZentarisInc.(N...maceuticalcompanyfocusedonendocrinetherapyandoncol...tudywithitstargetedcytotoxicpeptideconjugate,AEZS-...entendometrialcancer.Inapersonalizedhealthcareappr...
(Date:11/24/2009)...,Calif.,Nov.24/PRNewswire-FirstCall/--GenomicHealt...GenomicHealth,sExecutiveChairman,willpresentatthe2...CityonTuesday,December1,2009at10:00a.m.ET. ,, T...resentation,visittheInvestorRelationssectionofGeno....com .Pleaseconnecttothewebsiteatleast15minutespri...
(Date:11/24/2009)....24/PRNewswire-FirstCall/--CellTherapeutics,Inc.(C...stAnnualPiperJaffrayHealthCareConference.Theconfer...otel. ,, CTIwillpresentonTuesday,December1at11:...castofCTI,spresentationwillbeavailableat www.cellt...afterwards. , ,PiperJaffrayHealthCareConference,N...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2
... BOSTON, Jan. 15 PAREXEL International Corporatio...tical services organization, announced today it ha...ident and Chief Information Officer (CIO). Ms. Hop...mation technology (IT) initiatives and integrating... global basis. , , Prior to joining PAREXEL, Ms. ...
... ST. LOUIS, Jan. 14 As the latest step in its..., Monsanto Company,(NYSE: MON ) today announced ...increase in the quarterly dividend on its common s...are. The dividend is payable on April 24, 2009 to,...we have often said, when farmers succeed we succee...
... LAVAL, QC, Jan. 14 /PRNewswire-FirstCall/ - BioSy...veloping biotherapeutic thermogels for regenerativ...enrolment next month for the Canadian-European piv...Gel(R). To date, the Company has enrolled more tha...l be permitted to enrol additional subjects until ...
Other Biology Technology:PAREXEL Appoints Josephine Hoppe to Chief Information Officer 2PAREXEL Appoints Josephine Hoppe to Chief Information Officer 3PAREXEL Appoints Josephine Hoppe to Chief Information Officer 4Monsanto Board Approves 10 Percent Dividend Increase 2BioSyntech to conclude enrolment for pivotal BST-CarGel(R) trial in February 2009 2BioSyntech to conclude enrolment for pivotal BST-CarGel(R) trial in February 2009 3BioSyntech to conclude enrolment for pivotal BST-CarGel(R) trial in February 2009 4
...micron range are part of your production or produc...particle size is important to you. You need an ana...ations in your sample every time. The N5 Submicron...ectroscopy (PCS) , which determines particle size ...
MiniMACS Separation Unit from Miltenyi Biotec
...body Binding: High, 400 ng IgG/cm 2 (1cm2 = 100 &.../Ionic , Performance Certified: Well-to-Well, CV =...me: 360 µl , Packaging: 5 plates per sealed ...ene formulation , High antibody binding surface im...
SILVER SEQUENCE Staining Reagents from Promega
Biology Products: